Digital Making sense of differing digital health funding reports Digital health venture funding had a ridiculous, bonkers, blockbuster year.
Views & Analysis US loses, EU wins as Chinese biotech investment shifts focus Chinese biotech investors are taking an interest in the European market as diplomatic relations with the US become strained.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
